Introduction: The Silent Decline Driving How You Age
There’s a graph that every longevity researcher knows. It shows NAD+ levels in human tissue plotted against age. The line goes in one direction: down. By age 50, most people have lost 40-50% of the NAD+ they had at 20. By 70, the decline can exceed 60%.
This isn’t just an interesting data point. NAD+ decline is now considered one of the fundamental drivers of aging — a root cause, not merely a symptom. When NAD+ falls below critical thresholds, the cellular machinery that keeps you healthy starts to malfunction. Understanding this decline — and taking action to address it — is one of the most impactful things you can do for your long-term health.
What Causes NAD+ to Decline
NAD+ decline isn’t caused by a single factor. It’s the result of multiple converging biological processes.
Increased CD38 activity is one of the primary culprits. CD38 is an enzyme that consumes NAD+ as part of the immune response. As chronic, low-grade inflammation (sometimes called “inflammaging”) increases with age, CD38 activity rises, burning through NAD+ stores faster than they can be replenished.
DNA damage accumulation also plays a major role. Every day, your cells sustain tens of thousands of DNA damage events from normal metabolic processes, environmental toxins, and UV radiation. The enzyme PARP1, which repairs this damage, requires NAD+ as fuel. As damage accumulates with age, PARP1 consumes more and more NAD+.
Decreased NAD+ biosynthesis compounds the problem. The enzymes responsible for producing NAD+ from dietary precursors (like NAMPT) become less efficient with age, reducing the body’s ability to replenish its stores.
The result is a supply-and-demand crisis: demand for NAD+ increases while supply decreases. This drives a cascade of downstream effects that manifest as the symptoms and diseases of aging.
The Downstream Consequences of Low NAD+
When NAD+ levels fall, multiple critical systems are affected simultaneously.
Mitochondrial dysfunction is perhaps the most immediately noticeable. Mitochondria — your cells’ power plants — depend on NAD+ for energy production. Low NAD+ means less ATP, which you experience as fatigue, reduced stamina, and slower recovery. Over time, mitochondrial dysfunction contributes to virtually every age-related disease.
Impaired DNA repair leads to genomic instability, accumulating mutations, and cellular senescence — the state where cells stop dividing but don’t die, instead secreting inflammatory compounds that damage surrounding tissue.
Sirtuin deactivation occurs because the sirtuin family of proteins can’t function without NAD+. When sirtuins go offline, the body loses critical regulation of inflammation, metabolism, stress response, and circadian rhythm. Research in animal models has shown that restoring sirtuin activity through NAD+ repletion can reverse many aspects of aging.
Neurodegeneration is also linked to NAD+ decline. Brain cells are among the most metabolically active in the body and are particularly vulnerable to NAD+ depletion. Declining NAD+ in the brain is associated with cognitive decline, reduced neuroplasticity, and increased risk of neurodegenerative conditions.
Can You Restore NAD+ Levels?
The encouraging news is that NAD+ levels are not fixed. Research has demonstrated that NAD+ repletion through direct supplementation or precursor administration can meaningfully raise NAD+ levels in human tissues.
However, not all approaches are equally effective. Over-the-counter NAD+ precursors like NMN and NR can raise NAD+ modestly, but their oral bioavailability is limited and the quality of commercial supplements varies widely.
Clinical-grade NAD+ therapy — the kind offered through Luvo’s longevity program — provides several advantages. Luvo’s NAD+ injection delivers the molecule directly, bypassing digestive losses for maximum impact. NAD+ oral liquid drops use sublingual delivery for improved absorption over standard capsules. NAD+ nasal spray offers rapid mucosal absorption with potential cognitive advantages.
The choice of delivery method, dosing, and frequency should be tailored to your individual needs — which is exactly what Luvo’s clinical team provides.
When Should You Start NAD+ Therapy?
The decline in NAD+ begins in your 30s and accelerates through your 40s and 50s. Many longevity experts argue that proactive NAD+ repletion should begin before symptoms of decline become obvious — in other words, before you feel old, not after.
That said, patients at any adult age can benefit from NAD+ therapy. If you’re experiencing unexplained fatigue, cognitive fog, slow recovery, or a general sense that your body isn’t performing the way it used to, declining NAD+ may be a contributing factor.
Luvo’s longevity program can help you assess your needs and build a NAD+ protocol — whether standalone or as part of a comprehensive longevity approach including Sermorelin and Vitamin B12/MIC. Explore our NAD+ options: injection, oral liquid drops, and nasal spray.
